In the context of a previous negative biopsies but high risk of PCa, the decision to rebiopsy is typically guided by PSA (density >0.15 ng ml−1/cc or velocity >0.75 ng/ml/year),29 clinical findings and suspicion, initial MRI suspicion and possibly a repeat MRI. The gene discussed is KLK3; the disease is posterior cortical atrophy.